BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Royalty Pharma 

110 East 59th Street
33rd Floor
New York  New York  10022  U.S.A.
Phone: (212)-883-0200 Fax: (212)-883-2260


SEARCH JOBS





Segment
Pharmaceuticals





 Company News
Royalty Pharma Smacks Down $510 Million For Additional Interest In Biogen Idec, Inc. (Massachusetts) (BIIB)'s TECFIDERA® 1/6/2014 6:43:43 AM
Game May Not be Over for Royalty Pharma's Bid for Elan Corporation PLC (ELN) 6/28/2013 7:25:07 AM
Royalty Pharma Hostile Bid for Elan Corporation PLC (ELN) in Doubt After Vote 6/17/2013 7:51:25 AM
Elan Corporation PLC (ELN) Boss Martin Faces Ownership Showdown, Elan Risks Losing $2 Billion if Royalty Pharma Walks 6/13/2013 8:17:41 AM
Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan Corporation PLC (ELN) 6/11/2013 9:34:47 AM
Elan Corporation PLC (ELN) Board Rejects $6.7 Billion Royalty Pharma Offer 6/11/2013 7:17:38 AM
Royalty Pharma Raises Bid for Elan Corporation PLC (ELN) to Potential $8 Billion 6/7/2013 7:10:55 AM
Elan Corporation PLC (ELN) Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer 6/3/2013 10:31:40 AM
Royalty Pharma Increases Offer for Elan Corporation PLC (ELN) to $12.50 Per Share in All Cash 5/21/2013 9:42:00 AM
Royalty Pharma Raises Elan Corporation PLC (ELN) Bid to $12.50 a Share in Cash 5/21/2013 7:35:56 AM
123